Follow the LP
GPs may grab all the headlines—and make all the dollars—but LPs remain the industry's lifeblood. Here, three leading institutional investors give us their take on the most pressing issues facing their community.
GPs may grab all the headlines—and make all the dollars—but LPs remain the industry's lifeblood. Here, three leading institutional investors give us their take on the most pressing issues facing their community.
Copyright PEI Media
Not for publication, email or dissemination
